Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary Relapse
Xinyu Wan, Xiaomin Yang, Fan Yang, Tianyi Wang, Lixia Ding, Lili Song, Yan Miao, Xiang Wang, Yani Ma, Chengjuan Luo, Jingyan Tang, Longjun Gu, Jing Chen, Yanjing Tang, Jun Lu, Benshang Li
Cancer Res Treat. 2022;54(3):917-925. Published online 2021 Sep 17 DOI: https://doi.org/10.4143/crt.2021.399
Citations to this article as recorded by 
Difference in Efficacy and Safety of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Containing 4-1BB and CD28 Co-Stimulatory Domains for B-Cell Acute Lymphoblastic Leukemia
Lijuan Wu, Junchao Chen, Ruifen Cai, Xinrui Wang, Yixiao Liu, Qingshan Zheng, Lujin Li
Cancers.2023; 15(10): 2767. CrossRef
Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: a review
Franco Locatelli, Bijal Shah, Tracy Thomas, Kelly Velasco, Babatunde Adedokun, Ibrahim Aldoss, Lia Gore, Dieter Hoelzer, Renato Bassan, Jae H. Park, Nicolas Boissel, Hagop Kantarjian
Leukemia & Lymphoma.2023; 64(10): 1615. CrossRef
Using the Power of Junctional Adhesion Molecules Combined with the Target of CAR-T to Inhibit Cancer Proliferation, Metastasis and Eradicate Tumors
Christopher Mendoza, Dario Mizrachi
Biomedicines.2022; 10(2): 381. CrossRef
Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy
Elizabeth M. Holland, Bonnie Yates, Alex Ling, Constance M. Yuan, Hao-Wei Wang, Maryalice Stetler-Stevenson, Michael LaLoggia, John C. Molina, Daniel A. Lichtenstein, Daniel W. Lee, John A. Ligon, Haneen Shalabi, Mark A. Ahlman, Nirali N. Shah
Blood Advances.2022; 6(7): 2167. CrossRef
Efficacy and safety of CD19 CAR-T cell therapy for patients with B cell acute lymphoblastic leukemia involving extramedullary relapse
Luo HUANG, Mingming ZHANG, Guoqing WEI, Houli ZHAO, Yongxian HU, He HUANG
Journal of Zhejiang University (Medical Sciences).2022; 51(2): 151. CrossRef
Results of ARI‐0001 CART19 cell therapy in patients with relapsed/refractory CD19‐positive acute lymphoblastic leukemia with isolated extramedullary disease
Valentín Ortiz‐Maldonado, Anna Alonso‐Saladrigues, Marta Español‐Rego, Nuria Martínez‐Cibrián, Anna Faura, Laura Magnano, Albert Català, Daniel Benítez‐Ribas, Eva Giné, Marina Díaz‐Beyá, Juan Gonzalo Correa, Montserrat Rovira, Mercedes Montoro‐Lorite, Ale
American Journal of Hematology.2022; 97(6): 731. CrossRef
Umbilical cord blood: A promising source for allogeneic CAR-T cells
Dian-Dian Liu, Wei-Cong Hong, Kun-Yin Qiu, Xin-Yu Li, Yong Liu, Li-Wen Zhu, Wei-Xin Lai, Han- Chen, Hua-Qing Yang, Lu-Hong Xu, Jian-Pei Fang
Frontiers in Oncology.2022;[Epub] CrossRef
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin
Sabine Kayser, Chiara Sartor, Marlise R. Luskin, Jonathan Webster, Fabio Giglio, Nydia Panitz, Andrew M. Brunner, Matthias Fante, Christoph Lutz, Daniel Wolff, Anthony D. Ho, Mark J. Levis, Richard F. Schlenk, Cristina Papayannidis
Haematologica.2022; 107(9): 2064. CrossRef